Eli Lilly & Co. | Cash Flow
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
4,685
2,391
2,408
2,738
204
3,232
Depreciation, Depletion & Amortization
1,446
1,379
1,428
1,497
1,567
1,609
Other Funds
-
187
139
301
364
2,735
Funds from Operations
6,128
4,406
3,691
5,335
2,411
7,903
Changes in Working Capital
393
39
918
484
3,205
2,379
Net Operating Cash Flow
5,735
4,367
2,773
4,851
5,616
5,525
Capital Expenditures
1,093
1,566
1,626
1,092
2,164
Sale of Fixed Assets & Businesses
179
15
93
73
41
Purchase/Sale of Investments
1,018
3,623
1,162
1,945
563
Net Investing Cash Flow
2,073
3,909
27
3,139
3,784
Cash Dividends Paid - Total
2,121
2,101
2,127
2,159
2,192
Issuance/Reduction of Debt, Net
11
2,639
182
2,500
2,999
Net Financing Cash Flow
3,829
75
2,919
560
143
Net Change in Cash
189
41
205
916
1,954
Free Cash Flow
4,723
3,205
1,707
3,814
4,539
Deferred Taxes & Investment Tax Credit
286
36
748
440
788
327
Net Assets from Acquisitions
44
551
5,283
45
882
Other Sources
-
-
5,816
-
-
Change in Capital Stock
1,698
800
750
600
300
Exchange Rate Effect
22
342
86
236
21
Other Uses
97
5,430
134
130
216
About Eli Lilly &
View Profile
